| Literature DB >> 30663246 |
Takafumi Sugihiro1, Masayasu Yoneda1, Haruya Ohno1, Kenji Oki1, Noboru Hattori1.
Abstract
AIMS/Entities:
Keywords: Diabetes mellitus; Nutrient intake; Obesity
Mesh:
Year: 2019 PMID: 30663246 PMCID: PMC6717818 DOI: 10.1111/jdi.13010
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Figure 1Study participants. BMI, body mass index; NGT, normal glucose tolerance.
Baseline clinical characteristics
| Lean (BMI of <25 kg/m2) | Obese (BMI of ≥25 kg/m2) | |||
|---|---|---|---|---|
| Did not develop DM | Developed DM | Did not develop DM | Developed DM | |
|
| 535 | 41 | 153 | 36 |
| Men/women | 202/333 | 20/21 | 84/69 | 19/17 |
| Age (years) | 58.2 ± 14.0 | 61.2 ± 11.0 | 58.4 ± 13.4 | 57.0 ± 11.1 |
| BMI (kg/m2) | 21.6 ± 2.1 | 22.1 ± 2.0 | 27.3 ± 2.2 | 27.6 ± 2.0 |
| SBP (mmHg) | 128.0 ± 18.3 | 129.0 ± 16.6 | 136.0 ± 18.9 | 133.0 ± 14.4 |
| DBP (mmHg) | 75.9 ± 10.0 | 76.9 ± 9.5 | 79.3 ± 10.7 | 78.1 ± 10.6 |
| T‐cho (mg/dL) | 220.0 ± 39.6 | 222.0 ± 31.5 | 223.0 ± 36.6 | 237.0 ± 44.4 |
| TG (mg/dL) | 104.0 (75.0–148.0) | 106.0 (81.0–185.0) | 123.0 (92.5–161.0) | 169.0 (110.0–242.0) |
| FSG (mg/dL) | 86.6 ± 8.3 | 92.9 ± 9.3 | 89.6 ± 8.6 | 92.8 ± 9.1 |
| 2‐h SG (mg/dL) | 97.5 ± 21.6 | 113.0 ± 22.3 | 105.0 ± 19.8 | 112.0 ± 17.0 |
| FIRI (μU/mL) | 12.0 (9.0–14.0) | 13.0 (9.5–14.5) | 15.0 (11.0–19.0) | 16.0 (11.3–19.8) |
| HOMA‐IR | 2.46 (1.80–3.18) | 3.02 (2.07–3.42) | 3.16 (2.42–3.99) | 3.67 (2.41–4.57) |
| HOMA‐β | 180.0 (128.0–246.0) | 144.0 (110.0–180.0) | 203.0 (137.0–272.0) | 175.0 (129.0–284.0) |
Data are expressed as number, mean ± standard deviation or median (interquartile range). P‐values were calculated using unpaired t‐test. Parameters were transformed logarithmically before the analysis. † P < 0.05 between lean individuals who did and did not develop diabetes mellitus (DM). ‡ P < 0.05 between obese individuals who did and did not develop DM. § P < 0.05 between obese and lean individuals who developed DM. 2‐h SG, 2‐h serum glucose after the oral glucose tolerance test; BMI, body mass index; DBP, diastolic blood pressure; FIRI, fasting immunoreactive insulin; FSG, fasting serum glucose; HOMA‐β, homeostasis model assessment of β‐cell function; HOMA‐IR, homeostasis model assessment‐insulin resistance; SBP, systolic blood pressure; T‐cho, total cholesterol; TG, triglycerides.
Baseline nutrient intakes
| Lean (BMI of <25 kg/m2) | Obese (BMI of ≥25 kg/m2) | |||
|---|---|---|---|---|
| Did not develop DM | Developed DM | Did not develop DM | Developed DM | |
| Total energy (kcal) | 1,960 ± 603 | 2,050 ± 593 | 2,190 ± 750 | 2,120 ± 685 |
| Total protein (g) | 69.4 ± 21.1 | 73.6 ± 20.8 | 79.4 ± 27.8 | 78.7 ± 22.6 |
| Animal protein (g) | 39.4 ± 15.7 | 41.5 ± 15.0 | 45.9 ± 21.2 | 47.1 ± 16.2 |
| Vegetable protein (g) | 30.1 ± 9.1 | 32.2 ± 9.0 | 33.5 ± 11.1 | 31.6 ± 12.6 |
| Total fat (g) | 65.1 ± 25.7 | 69.3 ± 28.1 | 77.8 ± 34.2 | 76.8 ± 25.9 |
| Animal fat (g) | 31.2 ± 15.5 | 32.9 ± 15.2 | 35.8 ± 20.2 | 38.0 ± 16.7 |
| Vegetable fat (g) | 33.9 ± 14.3 | 36.4 ± 16.9 | 42.0 ± 18.9 | 38.8 ± 15.6 |
| Total carbohydrates (g) | 259.0 ± 76.8 | 271.0 ± 72.8 | 274.0 ± 82.9 | 267.0 ± 101.0 |
| Simple carbohydrates (g) | 82.7 ± 40.5 | 83.1 ± 40.2 | 87.5 ± 43.4 | 87.6 ± 50.0 |
| Sugar (g) | 37.3 ± 25.7 | 39.7 ± 25.4 | 38.4 ± 25.8 | 44.0 ± 35.0 |
| Fructose (g) | 45.4 ± 29.7 | 43.4 ± 28.9 | 49.1 ± 31.2 | 43.6 ± 33.6 |
| Complex carbohydrates (g) | 176.0 ± 59.8 | 188.0 ± 54.7 | 186.0 ± 65.1 | 180.0 ± 68.8 |
| PUFA (g) | 19.1 ± 6.9 | 20.7 ± 8.2 | 23.3 ± 9.2 | 22.1 ± 8.3 |
| SFA (g) | 20.9 ± 9.2 | 22.1 ± 9.3 | 24.6 ± 12.2 | 25.1 ± 10.1 |
Data are expressed as mean ± standard deviation. Unpaired t‐tests were used to compare the groups that did and did not develop diabetes mellitus (DM). PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.
Risks of developing diabetes mellitus according to nutrient intakes/total energy (body mass index of <25 kg/m2)
| Hazard ratio (95% CI) |
| |
|---|---|---|
| Total energy/IBW (kcal/kg) | 1.00 (0.97–1.03) | 0.974 |
| Total protein/TE (%) | 1.08 (0.93–1.24) | 0.308 |
| Animal protein/TE (%) | 1.04 (0.90–1.21) | 0.590 |
| Vegetable protein/TE (%) | 1.11 (0.87–1.43) | 0.396 |
| Total fat/TE (%) | 1.02 (0.96–1.07) | 0.574 |
| Animal fat/TE (%) | 1.01 (0.94–1.09) | 0.736 |
| Vegetable fat/TE (%) | 1.02 (0.95–1.09) | 0.671 |
| Total carbohydrates/TE (%) | 1.03 (0.98–1.07) | 0.276 |
| Simple carbohydrates/TE (%) | 0.99 (0.94–1.04) | 0.694 |
| Sugar/TE (%) | 1.02 (0.94–1.10) | 0.725 |
| Fructose/TE (%) | 0.98 (0.93–1.04) | 0.509 |
| Complex carbohydrates/TE (%) | 1.04 (0.99–1.08) | 0.136 |
| PUFA/TE (%) | 1.06 (0.91–1.23) | 0.469 |
| SFA/TE (%) | 1.04 (0.91–1.19) | 0.587 |
The hazard ratios were calculated after adjusting for age, sex, body mass index, systolic blood pressure, total cholesterol, triglycerides, fasting serum glucose and fasting immunoreactive insulin. The mean duration of the follow‐up period was 10.8 ± 6.6 years (mean ± standard deviation). CI, confidence interval; IBW, ideal bodyweight; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids; TE, total energy.
Risks of developing diabetes mellitus according to nutrient intakes/total energy (body mass index of ≥25 kg/m2)
| Hazard ratio (95% CI) |
| |
|---|---|---|
| Total energy/IBW (kcal/kg) | 0.96 (0.93–1.00) | 0.059 |
| Total protein/TE (%) | 1.22 (1.03–1.45) | 0.025 |
| Animal protein/TE (%) | 1.20 (1.04–1.38) | 0.011 |
| Vegetable protein/TE (%) | 0.82 (0.62–1.09) | 0.173 |
| Total fat/TE (%) | 1.04 (0.99–1.10) | 0.138 |
| Animal fat/TE (%) | 1.09 (1.02–1.17) | 0.010 |
| Vegetable fat/TE (%) | 0.98 (0.91–1.05) | 0.527 |
| Total carbohydrates/TE (%) | 0.98 (0.94–1.03) | 0.523 |
| Simple carbohydrates/TE (%) | 0.99 (0.93–1.05) | 0.696 |
| Sugar/TE (%) | 1.06 (0.98–1.14) | 0.133 |
| Fructose/TE (%) | 0.94 (0.88–1.01) | 0.089 |
| Complex carbohydrates/TE (%) | 0.99 (0.94–1.05) | 0.726 |
| PUFA/TE (%) | 0.99 (0.84–1.15) | 0.848 |
| SFA/TE (%) | 1.14 (1.00–1.30) | 0.047 |
The hazard ratios were calculated after adjusting for age, sex, body mass index, systolic blood pressure, total cholesterol, triglycerides, fasting serum glucose and fasting immunoreactive insulin. The mean duration of the follow‐up period was 10.7 ± 6.3 years (mean ± standard deviation). CI, confidence interval; IBW, ideal body weight; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids; TE, total energy.
Risks of developing obesity according to nutrient intakes/total energy
| Hazard ratio (95% CI) |
| |
|---|---|---|
| Total energy/IBW (kcal/kg) | 0.99 (0.97–1.01) | 0.461 |
| Total protein/TE (%) | 0.89 (0.81–0.98) | 0.017 |
| Animal protein/TE (%) | 0.94 (0.85–1.03) | 0.182 |
| Vegetable protein/TE (%) | 0.82 (0.68–0.99) | 0.049 |
| Total fat/TE (%) | 0.98 (0.95–1.02) | 0.347 |
| Animal fat/TE (%) | 0.98 (0.93–1.03) | 0.375 |
| Vegetable fat/TE (%) | 0.99 (0.94–1.04) | 0.661 |
| Total carbohydrates/TE (%) | 1.04 (1.01–1.07) | 0.018 |
| Simple carbohydrates/TE (%) | 1.07 (1.04–1.10) | <0.001 |
| Sugar/TE (%) | 1.09 (1.04–1.14) | <0.001 |
| Fructose/TE (%) | 1.05 (1.01–1.08) | 0.011 |
| Complex carbohydrates/TE (%) | 0.97 (0.93–0.99) | 0.047 |
| PUFA/TE (%) | 0.96 (0.87–1.07) | 0.488 |
| SFA/TE (%) | 0.96 (0.88–1.06) | 0.436 |
The hazard ratios were calculated after adjusting for age, sex, body mass index, systolic blood pressure, total cholesterol, triglycerides, fasting serum glucose and fasting immunoreactive insulin. The mean duration of the follow‐up period was 10.4 ± 6.5 years (mean ± standard deviation). CI, confidence interval; IBW, ideal body weight; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids; TE, total energy.